rosiglitazone has been researched along with l 796449 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM | 1 |
| Berger, GD; Berger, J; Doebber, T; Han, W; MacNaul, K; Moller, DE; Mosley, R; Sahoo, SP; Santini, C; Tolman, RL; Wu, M | 1 |
| Henke, BR | 1 |
| Ahmad Noruddin, NA; Al-Najjar, BO; Shu-Chien, AC; Taha, MO; Tengku Muhammad, TS; Wahab, HA | 1 |
| Boscá, L; Castrillo, A; Hortelano, S; Mojena, M | 1 |
2 review(s) available for rosiglitazone and l 796449
| Article | Year |
|---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2000 |
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2004 |
3 other study(ies) available for rosiglitazone and l 796449
| Article | Year |
|---|---|
Phenylacetic acid derivatives as hPPAR agonists.
Topics: Animals; Blood Glucose; Dose-Response Relationship, Drug; Drug Design; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Phenylacetates; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Triglycerides | 2003 |
Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling.
Topics: Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Hep G2 Cells; Humans; Ligands; Models, Molecular; Molecular Structure; PPAR gamma; Quantitative Structure-Activity Relationship; ROC Curve; Stereoisomerism | 2011 |
Peroxisome proliferator-activated receptor-gamma-independent inhibition of macrophage activation by the non-thiazolidinedione agonist L-796,449. Comparison with the effects of 15-deoxy-delta(12,14)-prostaglandin J(2).
Topics: Anions; Apoptosis; Benzofurans; Blotting, Northern; Blotting, Western; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Cytosol; Dose-Response Relationship, Drug; Flow Cytometry; Genes, Reporter; Glutathione Transferase; I-kappa B Kinase; Immunohistochemistry; Kinetics; Ligands; Macrophage Activation; Macrophages; Microscopy, Confocal; NF-kappa B; Nitric Oxide; Phenylacetates; Plasmids; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Transfection | 2001 |